Optimizing Brain Drug Delivery: The Role of Nanosuspension in Enhancing Therapeutic Efficacy and Bioavailability

In today’s molecular medicine, delivering therapeutics through the blood-brain barrier to manage neurological disorders remains a challenge. This is one of the barriers, which could be potentially solved by nanotechnology; specifically, nanosuspensions are cited to be one of the most versatile and effective ways. Nanosuspensions of submicron size are a new approach for enhancing drug solubility, permeability through the blood-brain barrier, and the aspect that contributes to bioavailability. This work reveals the problems connected with penetration to the blood- -brain barrier and the notion of therapeutic application utilizing enhanced concepts, outlining the novelty of nanosuspension. It also provides extensive coverage of formulation methods, stabilizers, and particle size. Besides, the work also shows the kind of therapeutic agents that are supplied by nanosuspensions, such as small molecules, nucleic acids, and peptides, as a way of showing the versatility of the methodology. The focus is especially on the investigations performed in the last few years with the purpose of improving the therapeutic outcome and the delivery of drug carrier systems. Compared to other strategies, the work effectively evaluates the bioavailability of several brain-targeted drugs by means of nanosuspension technology. Therefore, this review suggests the possibility of using nanosuspensions for therapeutic brain targeting in view of unfulfilled demands of treating brain tumors, neurodegenerative diseases, and neurological disorders, which marks the beginning of a new period in the development of pharmaceutical science.